Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmaceutical companies and veterinary clinics, including clinical chemistry and immunoassay analysers, high quality reagents, and quality control material.
Miembro Platino
Productos Covid-19
Close

Covid-19 Randox Laboratories

Laboratorio clínico

SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing

Qnostics SARS-CoV-2 Typing are reactive and non-reactive controls intended for use with in-vitro assays for the determination of spike antibodies to SARS-CoV-2. These controls can be used on various analyzers, making them useful in determining precision of testing systems and allows for performance monitoring of multiple test systems.
Mas detalles

PRUEBAS AGRUPADAS PARA SARS-COV-2
Extensive SARS-CoV-2 Pooling

Extensive SARS-CoV-2 Pooling es un cartucho de prueba de PCR rápido en tiempo real que brinda resultados claros y concisos de manera oportuna, directamente en el punto de atención en el analizador Vivalytic.
Mas detalles

CONTROL DE ANTICUERPOS DEL SARS-COV-2
Acusera SARS-CoV-2 Antibody Control

El control de anticuerpos Acusera SARS-CoV-2 comprende controles reactivos y no reactivos para anti-SARS-CoV-2 y es compatible con la validación de ensayos y el monitoreo del rendimiento de rutina de los ensayos serológicos para COVID-19.
Mas detalles

PRUEBAS DE GRUPO PARA SARS-COV-2
Vivalytic SARS-CoV-2 Pooling Test

Vivalytic SARS-CoV-2 Pooling es un cartucho de prueba de PCR rápido en tiempo real que brinda resultados de manera oportuna, directamente en el punto de atención para permitir que el paciente tome rápidamente las precauciones recomendadas.
Mas detalles

SARS-CoV-2 IgG (RBD & NP) Test
SARS-CoV-2 IgG (RBD & NP) Array

The Randox SARS-CoV-2 IgG (RBD & NP) array utilizes patented biochip technology to simultaneously detect IgG antibodies against both leading COVID-19 diagnostic antigens; Spike Receptor Binding Domain (RBD) and Nucleocapsid protein (NP). Maximum sensitivity is ensured through detection of antibodies against both proteins making the assay superior compared to other commercially available serology tests where false negative results are common. Measurement of both RBD and NP IgG antibodies also provides an opportunity to discriminate vaccinated versus naturally infected individuals based on leading vaccine candidates.
Mas detalles

PRUEBA RÁPIDA PARA EL SARS-COV-2
Vivalytic SARS-CoV-2 Rapid 39 Minute Test

La prueba rápida de 39 minutos, Vivalytic SARS-CoV-2, es un cartucho de prueba de PCR, en tiempo real, con la marca CE, que proporciona resultados claros y concisos de manera oportuna, directamente en los puntos de atención.
Mas detalles

CONTROLES PARA PRUEBAS DE SARS-COV-2
Qnostics’ SARS-CoV-2(SCV2) Q Controls

Los controles de SARS-CoV-2 (SCV2) Q de Qnostics, son controles positivos de un solo uso destinados a respaldar la validación, verificación y monitoreo del rendimiento de los ensayos moleculares utilizados en las pruebas de SARS-CoV-2 (COVID-19).
Mas detalles

ANALIZADOR DE PCR
Vivalytic

El Vivalytic es la plataforma de PCR multiplex más completa y fácil de usar del mercado y ofrece la gama más amplia de opciones de prueba jamás vista para su tamaño.
Mas detalles

Cytokine Arrays
Cytokine Arrays

Randox offer testing solutions for a comprehensive range of cytokines, cytokine receptors and growth factors designed to assist with COVID-19 risk stratification, monitoring of treatment efficacy and recovery. Utilizing patented Biochip technology up to 12 cytokines and growth factors may be detected simultaneously from a single patient sample.
Mas detalles

PRUEBA DE SARS-COV-2 (COVID-19)
Vivalytic Viral Respiratory Tract Infection (VRI) Array

El Array de infección Viral del Tracto Respiratorio de Vivalytic para la detección del SARS-CoV-2 (COVID19) puede identificar el SARS-CoV-2 (COVID-19) y diferenciarlo de otras infecciones respiratorias con síntomas similares.
Mas detalles

Coronavirus COVID-19 Array
Coronavirus COVID-19 Array

The Randox COVID-19 Array targets genes for SARS-CoV-2 and for sarbecovirus (SARS, SARS like, SARS-CoV-2) and are in line with WHO and CDC recommendations. These genes represent conserved regions of the genome and have been chosen due to their sensitivity and specificity. Suitable for use with the Evidence Investigator from Randox, the Lo-Plex Molecular Assay for SARS-CoV-2 (COVID-19) detects both SARS-CoV-2 and Sarbecovirus (confirmatory target), to report COVID-19 positive patient samples.
Mas detalles

Coronavirus Array
Extended Coronavirus Array

Suitable for use with the Evidence Investigator from Randox, the Extended Coronavirus Array comprises six strains of coronavirus, including SARS-CoV-2. The wider panel delivers a more comprehensive respiratory screen allowing differentiation between COVID-19 and other respiratory viruses with similar symptoms, ultimately enabling better treatment decisions to be made.
Mas detalles
Facebook Twitter Google+ Linked in

SARS-CoV-2 IgG (RBD & NP) Test

Modelo: SARS-CoV-2 IgG (RBD & NP) Array
SARS-CoV-2 IgG (RBD & NP) Test

Descripción:

The Randox SARS-CoV-2 IgG (RBD & NP) array utilizes patented biochip technology to simultaneously detect IgG antibodies against both leading COVID-19 diagnostic antigens; Spike Receptor Binding Domain (RBD) and Nucleocapsid protein (NP). Maximum sensitivity is ensured through detection of antibodies against both proteins making the assay superior compared to other commercially available serology tests where false negative results are common.
Más info

Descripción completa Características:

Descripción

The Randox SARS-CoV-2 IgG (RBD & NP) array utilizes patented biochip technology to simultaneously detect IgG antibodies against both leading COVID-19 diagnostic antigens; Spike Receptor Binding Domain (RBD) and Nucleocapsid protein (NP). Maximum sensitivity is ensured through detection of antibodies against both proteins making the assay superior compared to other commercially available serology tests where false negative results are common. Measurement of both RBD and NP IgG antibodies also provides an opportunity to discriminate vaccinated versus naturally infected individuals based on leading vaccine candidates.

Características:

• Simultaneous detection of IgG antibodies to RBD & NP maximizes assay sensitivity reducing false negatives
• Confirmation of an adaptative immune response to SARS-CoV-2
• Distinguish vaccinated from naturally infected individuals
• Specificity of 99.5% and sensitivity of 100% ≥ 14 days post SARS-CoV-2 PCR confirmation
• Identify incidence of SARS-CoV-2 infection in vaccinated individuals
• Qualitative and semi-quantitative results provided

Enviar un mensaje al proveedor

* Información requerida
* Email:
Para
Randox Laboratories ()
* Mensaje

Derecho de autor © 2000-2022 TradeMed.com. Todos los derechos reservados. | Términos y condiciones